Main > A2. TRADEMARK. INDEX. M-Mm > Mimpara

Product USA. A

GENERIC NAME Cinacalcet.HCl Tablets
STRUCTURE ((R)-N-(3-(3-(trifluoromethoxy)phenyl)proyl)-1-(1-naphthyl)ethylamine
INDICATION'S APPROVED INDICATIONS
- HyperCalemia of ParaThyroid Cancer
- Sec. HyperParaThyroidism>End Stage Re
nal Disease
- Sec. HyperParaThyroidism>CKD Dialysis
NON-APPROVED INDICATIONS
- Primary HyperParaThyroidism (Ph. II)
- Sec. HyperParaThyroidism>CKD>Stages
3 & 4) (Ph. III)
MARKETER'S COUNTRY Europe
UPDATE 01.26.06
COMPANY This data is not available for free
LICENSEE Co
LICENSOR This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back